Who owns Moderna, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MRNA from SEC Form 13F filings across 1,044 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 1,044 institutions disclosed 311.0M shares of Moderna, Inc. worth $59.93B — about 77.6% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
1,044
13F holders
$59.93B
value, 2026 filers
77.6%
of shares outstanding (311.0M sh)
356
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MRNA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 59.0M | $11.35B | 0.5% | 14.7% | +13.7% |
| 2 | BlackRock, Inc. | 27.8M | $5.35B | 0.1% | 6.9% | -9.2% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 23.9M | $4.61B | 0.1% | 6% | +3.0% |
| 4 | Capital World Investors | 22.6M | $4.36B | 0.5% | 5.6% | +1.6% |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 15.8M | $3.04B | 0.1% | 3.9% | +1.3% |
| 6 | STATE STREET CORP | 15.5M | $2.98B | 0.1% | 3.9% | -1.6% |
| 7 | BAILLIE GIFFORD & CO | 11.4M | $2.20B | 2.1% | 2.9% | -37.2% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 10.2M | $1.97B | 0.1% | 2.6% | +5.5% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 7.6M | $1.47B | 0.1% | 1.9% | +36.3% |
| 10 | Theleme Partners LLP | 6.7M | $1.28B | 48.9% | 1.7% | -17.4% |
| 11 | MORGAN STANLEY | 6.0M | $1.16B | 0.1% | 1.5% | -36.9% |
| 12 | GOLDMAN SACHS GROUP INC | 5.9M | $1.14B | 0.1% | 1.5% | +27.2% |
| 13 | UBS Group AG | 5.0M | $968.5M | 0.1% | 1.3% | +12.7% |
| 14 | Flagship Pioneering, LLC | 4.6M | $892.0M | 45.6% | 1.2% | 0.0% |
| 15 | BNP PARIBAS FINANCIAL MARKETS | 4.0M | $770.0M | 0.3% | 1% | -8.6% |
| 16 | MILLENNIUM MANAGEMENT LLC | 3.9M | $749.8M | 0.2% | 1% | +787.8% |
| 17 | WELLINGTON MANAGEMENT GROUP LLP | 3.7M | $715.5M | 0.1% | 0.9% | +50.9% |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.2M | $619.4M | 0.1% | 0.8% | -33.5% |
| 19 | NORTHERN TRUST CORP | 3.0M | $579.0M | 0.1% | 0.7% | +0.7% |
| 20 | Qube Research & Technologies Ltd | 2.9M | $562.9M | 0.5% | 0.7% | +222.3% |
| 21 | Invesco Ltd. | 2.6M | $505.0M | 0.0% | 0.7% | -54.6% |
| 22 | JPMORGAN CHASE & CO | 2.6M | $525.8M | 0.0% | 0.6% | +206.2% |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.4M | $466.6M | 0.0% | 0.6% | +577.2% |
| 24 | Merck & Co., Inc. | 2.3M | $444.5M | 54.2% | 0.6% | 0.0% |
| 25 | CITIGROUP INC | 2.3M | $436.5M | 0.1% | 0.6% | +4.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.